🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An open label, balanced, randomized, single dose, two treatment, two sequen...
Status
Completed
Location
Veeda Clinical Research Ltd.
Start Date
2024-12-23
Trial ID
NCT06932159
Treatments Being Tested
A randomized, multi-center study evaluating MET409 (50 mg) alone or in comb...
Status
Unknown
Location
Metacrine Investigative Site
Start Date
2020-12-15
Trial ID
NCT04702490
Treatments Being Tested
To investigate the relative bioavailability of BI 10773 following coadminis...
Status
Completed
Location
1245.58.1 Boehringer Ingelheim Investigational Site
Start Date
2011-02
Trial ID
NCT01301742
Treatments Being Tested
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1245.10.10026 Boehringer Ingelheim Investigational Site
Start Date
2008-08
Trial ID
NCT00749190
Treatments Being Tested
The trial is being conducted to establish the bioequivalence of emp/met (12...
Status
Completed
Location
1276.24.001 Boehringer Ingelheim Investigational Site
Start Date
2014-01
Trial ID
NCT02028767
Treatments Being Tested
A multicenter, open-label, single-arm study with regard to the efficacy and...
Status
Unknown
Location
Kobe University Hospital
Start Date
2019-09-01
Trial ID
NCT04018365
Treatments Being Tested
To determine and compare the rate and extent of absorption of a test formul...
Status
Unknown
Location
Multiple Locations
Start Date
2024-07-01
Trial ID
NCT06337409
Treatments Being Tested
gemigliptin,SGLT-2i DDI study...
Status
Unknown
Location
LG chem
Start Date
2018-04-05
Trial ID
NCT03565458
Treatments Being Tested
Idiopathic immunoglobulin A nephropathy (IgAN) is the most common biopsy-pr...
Status
Recruiting
Location
francesco paolo Schena
Start Date
2023-05-01
Trial ID
NCT04662723
Treatments Being Tested
Primary objective:To investigate if BI 10773 affects the pharmacokinetics o...
Status
Completed
Location
1245.45.1 Boehringer Ingelheim Investigational Site
Start Date
2011-01
Trial ID
NCT01284621